Navigation Links
Covaris Introduces Bench-top, AFA-based Process Technology
Date:3/25/2011

WOBURN, Mass., March 25, 2011 /PRNewswire/ -- Covaris Incorporated today announced the introduction of the Bench-top SF220 High Performance Formulation Processing System.

The SF220 system was designed to extend the company's ground-breaking Adaptive Focused Acoustics (AFA) technology to higher volume sample processing.  With the ability to process sample volumes from microliters through tens of liters, larger volume application areas such as Pre-clinical formulation, drug delivery systems, and biological processes (such as cell lysis, sonoporation, or transfection) can now "scale-up" the advantages of the proven AFA technology.

The Covaris SF220 system provides a solution for the problem of poorly soluble API's using the proprietary Covaris AFA Technology.  For example, adoption of the AFA-based SF220 system for preparation of DMPK formulations has been shown to improve quality of the studies by increasing the bioavailability, while reducing subjective content and improving operational efficiency.  Using AFA to accelerate dissolution can improve both the quality and efficiency of the drug development process, with unparalleled reproducibility, precision, and speed.  Demonstrated increases of solubility of over 90% have been achieved, while concurrently reducing the process time from over 2 days of stirring to under 3 minutes, and increasing the available API by over 2.5x due to a dramatic reduction in API degradation.   According to Jim Laugharn, Founder and CEO, "We at Covaris are very excited about the introduction of the new systems to meet the 'pent-up demand' our current customers have for processing larger sample volumes with AFA technology."  At present, Covaris has installed over 1,500 systems in over 30 countries worldwide.

AFA has also been demonstrated to formulate monodisperse, nano-emulsions with mean particle sizes of 20nm and an index below 0.100.  Liposomes can be produced using a simple lipid/water combination with the resulting single populations below 100nm.  The ability to reduce particle size of a crystalline API in water to below 15nm is possible.  All results were achieved using Adaptive Focused Acoustics TM (AFA) with very fast process times, non-contact, and isothermal operating conditions.

The Bench-top scale SF220 system is currently available from Covaris.  Pilot scale systems are currently in development.

About Covaris Inc.

Covaris, Inc. is a rapidly growing life science instrument company. Its proprietary instrument platform, based on patented Adaptive Focused Acoustic (AFA) technology brings unsurpassed speed and efficiency to biological and chemical sample preparation.  The AFA process, based on shock wave physics, delivers controlled, precise and accurate energy to biological and chemical samples. The process is non-contact, isothermal and rapid. Leading pharmaceutical and biotechnology companies worldwide are using Covaris instruments for DNA shearing, RNA extraction, Compound Dissolution and much more.

Information about Covaris is available at http://www.covarisinc.com


'/>"/>
SOURCE Covaris Incorporated
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Caliper and Covaris Establish Co-Marketing Agreement to Simplify Next Generation Sequencing
2. Covaris Receives the Society for Laboratory Automation and Screening (SLAS) New Product Award at LabAutomation 2011
3. Plans to Overhaul Ambulance Industry Met With Enthusiasm: Online Marketplace for Emergency Medical Services Introduces Largest Selection of Products and Services on the Web
4. CooperVision Introduces New Corporate Brand Identity
5. Akrimax Pharmaceuticals, LLC, Introduces NitroMist® (Nitroglycerin Lingual Aerosol) 400mcg/Spray
6. Merz Pharmaceuticals Introduces Comprehensive Programs to Provide Patients With Financial Assistance for Xeomin® (incobotulinumtoxinA)
7. Heska Introduces New Lactate Meter Analyzer
8. Deb Group Introduces First Real-time Hand Hygiene Group Monitoring System Based on World Health Organization Guidelines
9. MicroAire Introduces New SlimLine™ ECTR Cannula
10. Seal Shield Introduces iPad Keyboard and Case for Healthcare
11. Zimmer Spine Introduces Industrys First Porous Metal Cervical Interbody Device
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/13/2017)... 2017  New York City-based market research firm Kalorama Information ... aware of.  From new products to new costs, to the ... recently completed study, Potential Pipeline Disruptors . ... 1.  Age-Driven Growth - True Impact Moment Arriving ... the impact the growing population and, to a more extreme ...
(Date:7/11/2017)... ROCKVILLE, Md. , July 11, 2017  The ... had estimated revenues of approximately $394.1 million in 2016.  ... a trend of solid growth, in particular as a ... oncology clinical practice, and the recent introduction of a ... the need for less-invasive testing of tumor biomarkers to ...
(Date:7/10/2017)... GAITHERSBURG, Md. , July 10, 2017 ... in non-animal test methods, is the recipient of a ... by the PETA International Science Consortium. The device, which ... be used to expose human lung cells to airborne ... lung. IIVS will use the VITROCELL® system for testing ...
Breaking Medicine Technology:
(Date:7/21/2017)... ... 21, 2017 , ... The Margarian Law Firm has filed a class ... ale for allegedly containing no ginger. Dr. Pepper produces the “Canada Dry” brand of ... Margaryan alleges Canada Dry Ginger Ale claims on its bottle that it is made ...
(Date:7/21/2017)... ... July 21, 2017 , ... “Kids aren't born knowing how to ... shoes,” says Suzanne Tucker, Founder of St. Louis-based positive education company Generation Mindful. To ... Kickstarter on Monday, July 21st. , The kit uses colorful, engaging and educational ...
(Date:7/21/2017)... CANADA (PRWEB) , ... July 21, 2017 , ... ... torn anterior cruciate ligament (ACL) offer patients improved quality of life five years ... for Sports Medicine’s Annual Meeting in Toronto, Ontario, Canada. The study followed ...
(Date:7/20/2017)... Boston, MA (PRWEB) , ... July 20, 2017 ... ... aggressive form of blood and bone marrow cancer that progresses rapidly without treatment. ... often recommended to reduce the chance of reoccurrence and relapse. With such ...
(Date:7/20/2017)... ... July 20, 2017 , ... ... in which their iMedSecure™ comes included with each system installation. RMT’s iMedHD2™ ... to remote participants for real-time collaboration and immediate decision-making requirements. While never ...
Breaking Medicine News(10 mins):